Outcomes and endpoints in cancer trials: bridging the divide. (2015)
Attributed to:
Effective and efficient conduct of trials and meta-analyses
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(14)70380-8
PubMed Identifier: 25638556
Publication URI: http://europepmc.org/abstract/MED/25638556
Type: Journal Article/Review
Volume: 16
Parent Publication: The Lancet. Oncology
Issue: 1
ISSN: 1470-2045